These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Efficacy and safety of rush immunotherapy in patients with Hymenoptera allergy in Japan. Hirata H; Asakura T; Arima M; Cheng G; Honda K; Fukushima F; Yamaguchi B; Yoshida N; Fukuda T Asian Pac J Allergy Immunol; 2003 Jun; 21(2):89-94. PubMed ID: 14629126 [TBL] [Abstract][Full Text] [Related]
25. [Side effects of specific immunotherapy in patients with hymenoptera venom allergy]. Lata J; Specjalski K; Kołaczkowska M; Chełmińska M; Niedoszytko M; Jassem E Pneumonol Alergol Pol; 2005; 73(3):260-3. PubMed ID: 16989163 [TBL] [Abstract][Full Text] [Related]
26. [Hymenoptera venom allergy: what's new in 2023]. Belkoniene M; Ringwald M; Leimgruber A; Muller YD Rev Med Suisse; 2023 Apr; 19(821):663-667. PubMed ID: 37017347 [TBL] [Abstract][Full Text] [Related]
27. Tolerated sting challenge in patients on Hymenoptera venom immunotherapy improves health-related quality of life. Koschel DS; Schmies M; Weber CN; Höffken G; Balck F J Investig Allergol Clin Immunol; 2014; 24(4):226-30. PubMed ID: 25219104 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of hymenoptera venom allergy and poor adherence to immunotherapy in Austria. Bokanovic D; Aberer W; Griesbacher A; Sturm GJ Allergy; 2011 Oct; 66(10):1395-6. PubMed ID: 21635267 [No Abstract] [Full Text] [Related]
29. Stinging insect allergy: state of the art 2015. Tankersley MS; Ledford DK J Allergy Clin Immunol Pract; 2015; 3(3):315-22; quiz 323. PubMed ID: 25956310 [TBL] [Abstract][Full Text] [Related]
30. Insect sting reactions to bees, wasps, and ants. Steen CJ; Janniger CK; Schutzer SE; Schwartz RA Int J Dermatol; 2005 Feb; 44(2):91-4. PubMed ID: 15689203 [TBL] [Abstract][Full Text] [Related]
32. Immunotherapy for hymenoptera venom hypersensitivity. Müller U; Golden DB; Lockey RF; Shin B Clin Allergy Immunol; 2008; 21():377-92. PubMed ID: 18828518 [No Abstract] [Full Text] [Related]
33. [Preventive treatment of severe allergic complications caused by Hymenoptera venom. Our experience apropos of 250 cases]. Nataf P; Benitah E; Guinnepain MT; Herman D Ann Med Interne (Paris); 1985; 136(8):625-8. PubMed ID: 3833008 [TBL] [Abstract][Full Text] [Related]
34. An algorithm for the diagnosis and treatment of Hymenoptera venom allergy, 2024 update. Sturm GJ; Arzt-Gradwohl L Allergy; 2024 Aug; 79(8):2298-2301. PubMed ID: 38978291 [No Abstract] [Full Text] [Related]
35. Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy. Patriarca G; Nucera E; Roncallo C; Aruanno A; Lombardo C; Decinti M; Pascolini L; Milani M; Buonomo A; Schiavino D J Allergy Clin Immunol; 2009 Aug; 124(2):385; author reply 385-6. PubMed ID: 19482349 [No Abstract] [Full Text] [Related]
37. Insect venoms. Med Lett Drugs Ther; 1983 May; 25(636):53-4. PubMed ID: 6843487 [No Abstract] [Full Text] [Related]
38. A 5-year venom immunotherapy protocol with 50 μg maintenance dose: safety and efficacy in school children. Konstantinou GN; Manoussakis E; Douladiris N; Hatziioannou A; Giavi S; Saxoni-Papageorgiou P; Papadopoulos NG Pediatr Allergy Immunol; 2011 Jun; 22(4):393-7. PubMed ID: 21235631 [TBL] [Abstract][Full Text] [Related]
39. Effects of venom immunotherapy on serum level of CCL5/RANTES in patients with Hymenoptera venom allergy. Gawlik R; Glück J; Jawor B; Rogala B Immunopharmacol Immunotoxicol; 2015; 37(4):375-9. PubMed ID: 26181651 [TBL] [Abstract][Full Text] [Related]
40. Age-dependent sting recurrence and outcome in immunotherapy-treated children with anaphylaxis to Hymenoptera venom. Stritzke AI; Eng PA Clin Exp Allergy; 2013 Aug; 43(8):950-5. PubMed ID: 23889248 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]